InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
2.460
+0.200 (8.85%)
Oct 8, 2025, 4:00 PM EDT - Market closed

InMed Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Oct '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
64231026
Upgrade
Market Cap Growth
166.60%65.68%-23.21%-68.01%-62.35%-20.62%
Upgrade
Enterprise Value
-50-4-6516
Upgrade
Last Close Price
2.263.255.3118.53235.201590.00
Upgrade
PS Ratio
0.450.790.520.758.85-
Upgrade
PB Ratio
0.340.290.260.261.063.47
Upgrade
P/TBV Ratio
0.480.330.320.301.384.05
Upgrade
EV/Sales Ratio
-0.01--4.24-
Upgrade
Debt / Equity Ratio
0.060.060.110.030.090.04
Upgrade
Asset Turnover
0.360.360.360.310.10-
Upgrade
Inventory Turnover
2.942.942.441.33--
Upgrade
Quick Ratio
6.306.303.534.611.903.35
Upgrade
Current Ratio
6.996.994.415.662.893.78
Upgrade
Return on Equity (ROE)
-72.10%-72.10%-72.08%-75.09%-226.07%-153.95%
Upgrade
Return on Assets (ROA)
-36.12%-36.12%-39.22%-38.94%-75.28%-70.65%
Upgrade
Return on Capital (ROIC)
-40.66%-40.66%-44.89%-46.85%-96.98%-89.75%
Upgrade
Earnings Yield
-142.64%-208.04%-324.14%-257.74%-192.96%-39.86%
Upgrade
FCF Yield
-135.74%-197.97%-295.41%-241.44%-162.08%-38.25%
Upgrade
Buyback Yield / Dilution
-156.13%-156.13%-211.26%-336.59%-108.64%-28.72%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q